its all messed up
there are a lot of ppl that roam around and bash just for the heck of it. I can see this is an empty bag pump job, I don't own any shares, or shares loaned to me
big boys? did you check institutional ownership? there is practically none, this is owns by small individual investors
looks like GALE is going back to pre pump levels. Abstracts and other useless articles by seeking alph alha are getting old
float is in relatively tight hands, doesn't take much volume to move this either way.
Its too early in the game here, nothing significant will happen until midway to the end of clinical 2 trials, at the very earliest The patent PR with time stamp looked like a pump
there will be attempted pumps for this dog, it will take 3 or 4 years to see potential if it will get approved, usually mid term clinical 3
Havenger quit talking out your #$%$, shorts own this stock for a substantial profit, Most of it hedgies, they have unlimited bucks even if Dendreon is bought for 12+ which I expect. You look foolish on your stupid comments
its usually a 7 or 8 year process from clinical 1 to approval. Usually mid way thru clinical 3 there is a good indication if it could be approved. looking at 2018 at the earliest.